These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Indomethacin based new triazolothiadiazine derivatives: Synthesis, evaluation of their anticancer effects on T98 human glioma cell line related to COX-2 inhibition and docking studies. Sever B; Altıntop MD; Kuş G; Özkurt M; Özdemir A; Kaplancıklı ZA Eur J Med Chem; 2016 May; 113():179-86. PubMed ID: 26927686 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors. Chen Z; Wang ZC; Yan XQ; Wang PF; Lu XY; Chen LW; Zhu HL; Zhang HW Bioorg Med Chem Lett; 2015 May; 25(9):1947-51. PubMed ID: 25866240 [TBL] [Abstract][Full Text] [Related]
8. New pyrimidines and triazolopyrimidines as antiproliferative and antioxidants with cyclooxygenase-1/2 inhibitory potential. Omar AM; Abd El Razik HA; Hazzaa AA; El-Attar MA; El Demellawy MA; Abdel Wahab AE; El Hawash SA Future Med Chem; 2019 Jul; 11(13):1583-1603. PubMed ID: 31469327 [No Abstract] [Full Text] [Related]
9. Design, synthesis and biological evaluation of some novel benzothiazole/benzoxazole and/or benzimidazole derivatives incorporating a pyrazole scaffold as antiproliferative agents. Abdelgawad MA; Bakr RB; Omar HA Bioorg Chem; 2017 Oct; 74():82-90. PubMed ID: 28772160 [TBL] [Abstract][Full Text] [Related]
10. Exploration of isoxazole analogs: Synthesis, COX inhibition, anticancer screening, 3D multicellular tumor spheroids, and molecular modeling. Hawash M; Abdallah S; Abudayyak M; Melhem Y; Abu Shamat M; Aghbar M; Çapan I; Abualhasan M; Kumar A; Kamiński M; Góral T; Dominiak PM; Sobuh S Eur J Med Chem; 2024 May; 271():116397. PubMed ID: 38626522 [TBL] [Abstract][Full Text] [Related]
11. 1,2,3-triazole tethered Indole-3-glyoxamide derivatives as multiple inhibitors of 5-LOX, COX-2 & tubulin: Their anti-proliferative & anti-inflammatory activity. Naaz F; Preeti Pallavi MC; Shafi S; Mulakayala N; Shahar Yar M; Sampath Kumar HM Bioorg Chem; 2018 Dec; 81():1-20. PubMed ID: 30081353 [TBL] [Abstract][Full Text] [Related]
12. Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling. Vannini F; Chattopadhyay M; Kodela R; Rao PPN; Kashfi K Redox Biol; 2015 Dec; 6():318-325. PubMed ID: 26319435 [TBL] [Abstract][Full Text] [Related]
13. New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies. El-Sayed NA; Nour MS; Salem MA; Arafa RK Eur J Med Chem; 2019 Dec; 183():111693. PubMed ID: 31539778 [TBL] [Abstract][Full Text] [Related]
14. Benzoin Schiff Bases: Design, Synthesis, and Biological Evaluation as Potential Antitumor Agents. Sabbah DA; Al-Tarawneh F; Talib WH; Sweidan K; Bardaweel SK; Al-Shalabi E; Zhong HA; Abu Sheikha G; Abu Khalaf R; Mubarak MS Med Chem; 2018; 14(7):695-708. PubMed ID: 29651943 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents. Abolhasani H; Zarghi A; Komeili Movahhed T; Abolhasani A; Daraei B; Dastmalchi S Bioorg Med Chem; 2021 Feb; 32():115960. PubMed ID: 33477020 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, anti-inflammatory activity, and in vitro antitumor effect of a novel class of cyclooxygenase inhibitors: 4-(aryloyl)phenyl methyl sulfones. Harrak Y; Casula G; Basset J; Rosell G; Plescia S; Raffa D; Cusimano MG; Pouplana R; Pujol MD J Med Chem; 2010 Sep; 53(18):6560-71. PubMed ID: 20804197 [TBL] [Abstract][Full Text] [Related]
17. Ligand-Based Drug Design: Synthesis and Biological Evaluation of Substituted Benzoin Derivatives as Potential Antitumor Agents. Sabbah DA; Ibrahim AH; Talib WH; Alqaisi KM; Sweidan K; Bardaweel SK; Sheikha GA; Zhong HA; Al-Shalabi E; Khalaf RA; Mubarak MS Med Chem; 2019; 15(4):417-429. PubMed ID: 30207238 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, antitumour activities and molecular docking of thiocarboxylic acid ester-based NSAID scaffolds: COX-2 inhibition and mechanistic studies. El-Azab AS; Abdel-Aziz AA; Abou-Zeid LA; El-Husseiny WM; El Morsy AM; El-Gendy MA; El-Sayed MA J Enzyme Inhib Med Chem; 2018 Dec; 33(1):989-998. PubMed ID: 29806488 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, molecular docking and evaluation of novel sulfonyl hydrazones as anticancer agents and COX-2 inhibitors. Şenkardeş S; Han Mİ; Kulabaş N; Abbak M; Çevik Ö; Küçükgüzel İ; Küçükgüzel ŞG Mol Divers; 2020 Aug; 24(3):673-689. PubMed ID: 31302853 [TBL] [Abstract][Full Text] [Related]
20. Optimization of pyrrolizine-based Schiff bases with 4-thiazolidinone motif: Design, synthesis and investigation of cytotoxicity and anti-inflammatory potency. Shawky AM; Abourehab MAS; Abdalla AN; Gouda AM Eur J Med Chem; 2020 Jan; 185():111780. PubMed ID: 31655429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]